- Director of Illicit Drugs, Public Health and Policy Unit at the Centre for Addictions Research
- Pro to the question "Should Marijuana Be a Medical Option?"
“While further research is required on the biological and clinical aspects of the benefits of cannabis use for HCV [hepatitis C] treatment, and the effectiveness of cannabis use for HCV treatment needs to be explored in larger study populations, we advocate that in the interim existing barriers to cannabis use are removed for drug users undergoing HCV treatment until the conclusive empirical basis for evidence-based guidance is available.”
European Journal of Gastroenterology & Hepatology, Oct. 2006
- Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
- Involvement and Affiliations:
- Director, Illicit Drugs, Public Health and Policy Unit, Centre for Addictions Research, University of Victoria, 2006-present
- Former Research Scientist and Section Co-Head, Public Health and Regulatory Policy at the Centre for Addiction and Mental Health (CAMH), Toronto
- Former Associate Professor, Public Health Sciences and Criminology, University of Toronto
- Recipient, New Investigator Research Career Award, Canadian Institutes of Health Research, 2001-2006
- Recipient, Anthony Miller Research Award for Excellence in Research in Public Health; Department of Public Health Sciences, University of Toronto, 2003
- Recipient, IVO Award (biennial international award for research excellence in substance use/addiction studies); Addiction Research Institute (IVO), Rotterdam, Netherlands, 2002
- PhD, Criminology, University of Toronto, 1998
- None found
- Quoted in: